Immunization Graphs:

Natural Infectious Disease Declines; Immunization Effectiveness; and Immunization Dangers

Prepared by: Raymond Obomsawin Ph.D. December, 2009

FIGURE SET I.

Natural Infectious Disease Declines

Preceding Public Immunization Efforts

Figures one (1) through eleven (11) graphically illustrate that in North America, Europe, and the

South Pacific, major declines in life-threatening infectious diseases occurred historically either

without, or far in advance of public immunization efforts for specific diseases as listed. This

provides irrefutable evidence that vaccines are not necessary for the effective elimination of a

wide range of infectious diseases

0.00

100.00

200.00

300.00

400.00

500.00

600.00

700.00

800.00

1935 1947 1959 1971 1983

FIGURE 1 – CANADA

MEASLES

REPORTED INCIDENCE (1935-1983)

Source: Adapted from: Public Health Agency of Canada, Figure 8 – Measles Reported

Incidence Canada. http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-meas-roug-eng.php

Measles Vaccines

Introduced

Live 1963 / Inactivated 1964

NNoottee:: IInncciiddeennccee ddaattaa wwaass uunnaavvaaiillaabbllee

iinn tthhee ppeerriioodd ssppaannnniinngg 11995599--11996688

0.00

200.00

400.00

600.00

800.00

1,000.00

1,200.00

1850 1875 1900 1925 1950 1965

FIGURE 2 - ENGLAND & WALES

MEAN ANNUAL MEASLES MORTALITY CASES

CHILDREN UNDER 15 (1850-1965)

Source: McKeown, T., The Role of Medicine: Dream, Mirage or Nemesis?; Basil

Blackwell; Oxford, UK; 1979; p. 105; & Waltzkin, H., in The Relevance of Social Science

for Medicine; Springer; 1st edition, Dec. 31, 1980

Measles

Vaccination Begins

0

0.02

0.04

0.06

0.08

0.1

0.12

0.14

1919 1925 1931 1937 1943 1949 1955 1961 1967

SCURVY MEASLES

Measles Vaccination

Begins

Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England &

Wales; UK Office for National Statistics, 1997.

FIGURE 3 - ENGLAND

SCURVY & MEASLES

PARALLEL MORTALITY RATES PER 100,000

(1919-1967)

0.00

20.00

40.00

60.00

80.00

100.00

120.00

140.00

160.00

180.00

200.00

1880 1900 1924 1930 1936 1942 1948 1954 1960

BCG Vaccination

Introduced Between

1948-1954 (Depending

on Prov. or Terr.)

Source: Table based on data at: Timeline of TB in Canada http://www.lung.ca/tb/tbhistory/timeline/;

http://www.thecanadianencyclopedia.com/index.cfm?PgNm=TCE&Params=A1ARTA0008151

Public Health Agency of Canada: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-bcg-eng.php; and

PHAC on BCG usage in Canada: http://www.phac-aspc.gc.ca/tbpc-latb/bcgvac_1206-eng.php

FIGURE 4 – CANADA

TUBERCULOSIS MORTALITY

RATES PER 100,000 (1880-1960)

0.00

20.00

40.00

60.00

80.00

100.00

120.00

140.00

160.00

180.00

200.00

1900 1910 1920 1930 1940 1950 1960

No Vaccination for

Tuberculosis

Adopted in the USA

FIGURE 5 – UNITED STATES

TUBERCULOSIS MORTALITY

RATES PER 100,000 INFANTS (1900-1960)

Source: John H. Dingle; Life and Death in Medicine; Scientific American; 1973; p. 56.

0.00

200.00

400.00

600.00

800.00

1,000.00

1,200.00

1,400.00

1880 1890 1900 1910 1920 1930 1940 1950 1953 1960

FIGURE 6 - NEW ZEALAND

TUBERCULOSIS MORTALITY

RATES PER MILLION (1880-1960)

Source: Director General Annual Mortality Reports Covering 1872-1960, New Zealand

Parliamentary Journals for the Years Specified.

BCG Vaccination

Introduced

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

16.00

1918 1924 1930 1936 1942 1948 1954 1960

Pertussis

Vaccination Introduced

FIGURE 7 – UNITED STATES

MEAN ANNUAL PERTUSSIS MORTALITY

RATES PER 100,000 (1918-1960)

Source: Data derived from: Vital Statistics of the United States 1937-1960; and

Historical Statistics of the United States: Colonial Times to 1970 Part 1 Ch. B Vital

Statistics and Health and Medical Care, pp. 44-86H.

0.00

200.00

400.00

600.00

800.00

1,000.00

1,200.00

1,400.00

1850 1875 1900 1925 1950 1965

FIGURE 8 - ENGLAND & WALES

MEAN ANNUAL PERTUSSIS MORTALITY CASES

CHILDREN UNDER 15 (1850-1965)

Children under 15

PPeerrttuussssiiss

VVaacccciinnaattiioonn IInnttrroodduucceedd

Source: Thomas McKeown, The Role of Medicine: Dream, Mirage or Nemesis?; Basil

Blackwell; Oxford, UK; 1979; p. 103

0

0.02

0.04

0.06

0.08

0.1

0.12

0.14

0.16

0.18

1919 1925 1931 1937 1943 1949 1955 1961 1967

SCURVY PERTUSSIS

FIGURE 9 - ENGLAND

SCURVY & PERTUSSIS

PARALLEL MORTALITY RATES PER 100,000

(1919-1967)

Pertussis Vaccination

Begins

Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England &

Wales; UK Office for National Statistics, 1997.

0.00

2.00

4.00

6.00

8.00

10.00

12.00

1910 1916 1922 1928 1934 1940 1946 1952 1958

No Vaccination for

Scarlet Fever

Adopted in the USA

Source: Data derived from - Vital Statistics of the United States 1937-1960; and

Historical Statistics of the United States: Colonial Times to 1970 Part 1 Ch. B Vital

Statistics and Health and Medical Care, pp. 44-86H.

FIGURE 10 – UNITED STATES

MEAN ANNUAL SCARLET FEVER MORTALITY

RATES PER 100,000 (1910-1958)

0.00

20.00

40.00

60.00

80.00

100.00

120.00

140.00

160.00

180.00

1933 1937 1941 1945 1949 1953 1961 1965

FIGURE 11 – UNITED STATES

ANNUAL INFLUENZA MORTALITY

RATES PER 100,000 (1933-1965)

Source: Doshi, P., Trends in Recorded Influenza Mortality: United States 1900-2004,

American Journal of Public Health, May 2008, vol. 98, no. 5, p. 941.

Influenza vaccination

first widely administered

in the U.S. in the

late 1980s.

FIGURE SET II.

Immunization Effectiveness

Figures eleven (12) through twenty-four (24) graphically illustrate that immunization is not by

any means a proven and foolproof measure for protection from various infectious disease

conditions. It is often inconsequential epidemiologically, and in some cases it is shown to

actually worsen health-care outcomes.

0% Effective

Children Under 2 Yrs of Age

Inactivated Influenza Vaccine

Little or No Effectiveness

Elderly Living in Communities& Group Homes

Inactivated Influenza Vaccine

Source: Cochrane Collaboration Database of Systematic Reviews, (John Wiley & Sons, Ltd.)

2006 (1) Article No. CD004879 – Covers 51 Studies on 260,000 children

Source: Cochrane Collaboration Database of Systematic Reviews, (John Wiley & Sons, Ltd.)

2006 (3) Article No. CD004876 – Covers 64 Studies, over 40 years of infuenza vaccination

and see: http://www.bmj.com/cgi/content/full/333/7574/912

Figure 12

Figure 13

0% Effective

0% Effective

BCG for Tuberculosis

Source: Randomised controlled trial of single BCG, repeated BCG, or combined BCG and

killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi;

The Lancet, Volume 348, Issue 9019, Pages 17 - 24, 6 July 1996

BCG for Tuberculosis

Note: Tuberculosis higher among two (2)

dose Vaccinated versus Placebo Group

Note: In years 0-2.5 the vaccinated had

double the incidence of Tuberculosis

versus Placebo Group

Source: Double blind randomized controlled trial of BCG’s effectiveness on 250,000 subjects

Tuberculosis Research Centre (ICMR), Chennai, India: Indian Journal of Medical Research,

110, August 1999, pp. 56-69.

Figure 14

Figure 15

92%

8% 92% Vaccinated

8% Unvaccinated

86%

14%

86% Vaccinated

14% Unvaccinated

2006

Iowa

MUMPS OUTBREAK IN HIGHLY

VACCINATED POPULATION

Source: Center for Disease Control , MMWR

55 (20); May 26, 2006; pp. 559-63.

2001

Oregon

CHICKENPOX OUTBREAK IN

HIGHLY VACCINATED POPULATION

Source: Pediatrics - Vol. 113;

No. 3; pp. 455-459; (2004)

Figure 16

Figure 17

90%

10% 90% Vaccinated

10% Unvaccinated

99%

1%

99% Vaccinated

1% Unvaccinated

1985

Texas

MEASLES OUTBREAK IN

HIGHLY VACCINATED POPULATION

Source: New England Journal of Medicine -

Vol. 316; No. 13; pp. 771-774; (1987)

1993

Ohio Source: N.Z. Miller; Vaccine Safety Manual; N.A. Press, Sante Fe, New Mexico; p. 140; (2008)

(Refers to CDC & Official Surveillance data)

PERTUSSIS OUTBREAK IN

HIGHLY VACCINATED POPULATION

Figure 18

Figure 19

0.00

200.00

400.00

600.00

800.00

1,000.00

1973 1974 1975 1976 1977 1978 1979 1980 1981 1982

FIGURE 20 - NIGERIA

DIPHTHERIA REPORTED CASES

(1973-1982)

Source: E. Ekanem; A 10-Year Review of Morbidity from Childhood Preventable

Diseases in Nigeria: How Successful is the Expanded Programme of Immunization

(EPI)?; Journal of Tropical Pediatrics, Vol. 34; No. 6; UK; 1988; pp. 323-328.

EPI Begins

Diphtheria Vaccine

0.00

100.00

200.00

300.00

400.00

500.00

1973 1974 1975 1976 1977 1978 1979 1980 1981 1982

FIGURE 21- NIGERIA

WHOOPING COUGH CASE RATES PER 100,000

(1973-1982)

EPI Begins

Pertussis Vaccine

Source: E. Ekanem; A 10-Year Review of Morbidity from Childhood Preventable

Diseases in Nigeria: How Successful is the Expanded Programme of Immunization

(EPI)?; Journal of Tropical Pediatrics, Vol. 34; No. 6; UK; 1988; pp. 323-328.

0.00

20.00

40.00

60.00

80.00

100.00

120.00

140.00

160.00

180.00

1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989

FIGURE 22 - DOMINICAN REPUBLIC

MEASLES CASE RATES PER 100,000

(1978-1989)

EPI Begins

Measles Vaccine

Sources: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6,

Santo Domingo, Dominican Republic, May 27, 1988; and Data for years 1988-1989 from

personal communication from PAHO, EPI Unit, Aug. 21, 1990.

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

1978 1979 1980 1981 1982 1983 1984 1985 1986 1987

FIGURE 23 - DOMINICAN REPUBLIC

DIPHTHERIA CASE RATES PER 100,000

(1978-1987)

Source: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6,

Santo Domingo, Dominican Republic, May 27, 1988.

EPI Begins

Diphtheria Vaccine

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

16.00

18.00

20.00

1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989

FIGURE 24 - DOMINICAN REPUBLIC

PERTUSSIS CASE RATES PER 100,000

(1978-1989)

EPI Begins

Pertussis Vaccine

Sources: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6,

Santo Domingo, Dominican Republic, May 27, 1988; and Data for years 1988-1989 from

personal communication from PAHO, EPI Unit, Aug. 21, 1990.

FIGURE SET III.

Immunization Dangers

Figures twenty-five (25) through thirty five (35) graphically illustrate that increases in the

number of governmental mandated vaccine doses correlates with significant increases in death

rates for children under the age of five (5); and that the practice is linked to sudden infant death

syndrome; various degenerative diseases, including diabetes; and appears to cause general

immune system impairment in infants and children. Evidence also points to the practice of

immunization as a principal factor in the recent massive increases in neurodegenerative

conditions such as autism in children.

0

1

2

3

4

5

6

7

8

9

FIGURE 25 - COUNTRIES & NUMBER

OF VACCINE DOSES MANDATED TO AGE 5

UNDER AGE 5 MORTALITY RATES FOR 2007

Under Age 5 Mortality per 1,000 Live Births

Mortality Increase Trendline

Under Age 5 Mortality statistics derived from: World Health Organization – World

Health Statistics 2009 Report http://www.who.int/whosis/whostat/EN_WHS09_Table1.pdf

& Govt. Mandated Vaccines figures derived from: Generation Rescue Inc. 2009

http://www.generationrescue.org/documents/SPECIAL%20REPORT%20AUTISM%202.pdf

0

10

20

30

40

50

60

70

80

90

1999 2000 2001 2002 2003

FIGURE 26 - UNDER AGE 5 INFLUENZA DEATHS

BEFORE AND AFTER U.S. CDC MANDATES

FLU VACCINES IN EARLY CHILDHOOD

Influenza Deaths Children Under Age 5

Under Age 5 Influenza Mortality statistics derived from: Center for Disease Control

Vital Statistics Reports covering Years 1999-2003 reported in Miller, N.Z., Vaccine

Safety Manual, New Atlantean Press, Sante Fe, New Mexico, 2008, p. 97.

Latter half of 2002 CDC Mandates

Early Childhood Flu Vaccines in USA

0%

10%

20%

30%

40%

50%

60%

70%

80%

0.5 1 3 7 14 21

FIGURE 27 - PERTUSSIS VACCINE &

SUDDEN INFANT DEATH SYNDROME

0

0.5

1

1.5

2

2.5

3

3.5

4

Ulcerative Colitis Crohn's Disease

Unvaccinated

Vaccinated

Post-Pertussis

Vaccination

70% of SIDS

Deaths Occurred

Within 3 Weeks

2/3 of 103 infants had been vaccinated with pertussis prior to death, of which 6.5% died within 12 hours; 13% within 24 hours; 26% within 3 days; 37%, 61% & 70% within 1, 2, & 3 weeks respectively. Source: Torch W., Neurology - 32 (4 – Pt. 2) A, 1982, pp. 169-170.

FIGURE 28 - MEASLES VACCINE &

INFLAMMATORY BOWEL DISEASES

Source:The Lancet - Vol. 345;

8957; 1995, pp. 1062-1063.

Days Post-Vaccination

0 0.5 1 1.5 2 2.5

Fever >40°

Ear Infections

Inflammationof the Throat

Aggressive Behaviour

Events

Convulsions/Collapse

Antibiotics Administered

0 20 40 60 80 100 120 140 160 180

Absolute Incidence (Non-Vaccinated in Relation to Vaccinated to N = 312 Per Group

Baby CriesOften

Sickly

Eczema

Asthma/Chronic

Lung Disease

AllergicReactions

Aggressive Behaviour

DifficultySleeping

Average Incidence First Five (5) years of Life Nederlands Vereniging Kritisch Prikken 2004 Survey Findings

Fully Vaccinated

No Vaccinations

Absolute Incidence N=543 Nederlands Vereniging Kritisch Prikken 2004 Survey Findings

Fully Vaccinated

No Vaccinations

FIGURE 29

FIGURE 30

0 5 10 15 20 25

Iceland

Luxembourg

Spain,

Catalonia

Belgium

Netherlands

Spain, Madrid

England

N. Ireland

Scotland

Denmark

Norway

0

20

40

60

80

100

120

140

Incidence - Insulin Dependant Diabetes Mellitus Percentage - Pertussis Immunization Coverage

1978/74 1979/75 1980/76 1981/77 1982/78 1983/79 1984/80 1985/81 1986/82 1987/83 1988/84 1985/86

NO BCG VACCINATIONS

BCG VACCINATIONS

Source: Infectious Disease in Clinical

Practice - No. 6, pp. 449-454; (1997)

Cumulative Incidence IDDM/1,000,000 UK

FIGURE 31

FIGURE 32

Source: Journal of Pediatric Endocrinology &

Metabolism, 16, pp. 495-508; (2003)

BCG Mandated in Schools & Diabetes Rates

Type 1 per 1000,000 – Children 0-14

http://childhealthsafety.wordpress.com/2009/06/03/japvaxautism/ Figure based on: Kihei

Terada et. al.; Alterations in epidemics and vaccination for measles during a 20 year

period and a strategy for elimination in Kurashiki City, Japan; Kawasaki Medical

School 2002 Mar; 76 (3):pp. 180-4. Correlated with: H. Honda et. al,; No effect of MMR

withdrawal on the incidence of autism: a total population study; Journal of Child

Psychology & Psychiatry; June 2005 (6); pp.572-579

FIGURE 33

0

2

4

6

8

10

12

14

16

18

20

0

5

10

15

20

25

1991 1992 1993 1994 1995 1996 1997

Rate of Autism per 10,000

Vaccine Mercury Exposure (x 10 = Micrograms)

Vaccine Mercury Burden &

Autism Rate California, USA

1991-1997 Surveys

FIGURE 34

Source: Adapted from Blaxil, M., Vaccine Mercury Burden & Autism Risk (US) IOM

7/2001, http://www.healing-arts.org/children/marksslide_files/slide0003.htm

Rate

VSD: Generation Zero

Source: http://www.evidenceofharm.com/UCSD.ppt#363,27,VSD: Generation Zero

FIGURE 35